| 标题： | 中国心力衰竭基层诊断与治疗指南（2024年） |
| title： | Chinese Guidelines for the Diagnosis and Treatment of Heart Failure (Primary Care Version, 2024) |
| 版本： | 更新版 |
| version： | Updated |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 基层医疗机构的全科医生和心血管医生 |
| Guide users： | General practitioners and cardiologists at the primary care level. |
| 证据分级方法： | 参考国际或国内相应专业的指南、共识或系统综述，结合基层实际情况给出证据等级及推荐 |
| Evidence grading method： | According to international or domestic professional guidelines, consensus or systematic review, combined with the actual situation at the primary care, providing evidence levels and recommendations. |
| 制定单位： | 中华医学会，中华医学会杂志社，中华医学会全科医学分会，中华医学会《中华全科医师杂志》编辑委员会，中国心衰中心联盟专家委员会，《中国心力衰竭基层诊断与治疗指南（2024年）》编写专家组 |
| Formulating unit： | Chinese Medical Association，Chinese Medical Association Publishing House，Chinese Society of General Practice，Editorial Board of Chinese Journal of General Practitioners of Chinese Medical Association, China Heart Failure Center Expert Committee, Expert Group on the Chinese Guidelines for the Diagnosis and Treatment of Heart Failure (Primary Care Version, 2024) |
| 注册时间： | 2024-03-21 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN434 |
| Registration number： | |
| 指南制订的目的： | 心力衰竭（心衰）已成为我国重要的公共卫生问题，患病率逐年上升。在基层医疗卫生机构，受资源和专业知识所限，心衰的管理存在一定困难。为此，中华医学会、中华医学会杂志社、中华医学会全科医学分会等多个组织、机构联合组织专家小组，结合最新的循证医学证据、国内外相关指南和我国基层医疗卫生机构的实际情况，制订了《中国心力衰竭基层诊断与治疗指南（2024年）》。本指南主要面向基层的全科医师和心血管科医师，以帮助他们在资源有限的情况下为心衰患者提供优质的医疗服务。 |
| Purpose of the guideline： | Heart failure has become a significant public health issue in China, with the incidence rate increasing annually. In primary healthcare institutions, due to limitations in resources and professional knowledge, the management of heart failure faces certain challenges. To address this, a panel of experts organized by various organizations and institutions, including the Chinese Medical Association, the Journal of the Chinese Medical Association, and the General Practice Division of the Chinese Medical Association, has developed the "Chinese Guidelines for the Diagnosis and Treatment of Heart Failure (Primary Care Version, 2024)" These guidelines, formulated based on the latest evidence-based medicine, relevant domestic and international guidelines, and the actual conditions of primary healthcare institutions in China, are primarily aimed at general practitioners and cardiologists in primary care settings. They are designed to help these healthcare providers offer high-quality medical services to patients with heart failure under resource-limited conditions. |
